MOTNF yields 20000000.00% · MRK yields 2.76%● Live data
📍 MOTNF pulled ahead of the other in Year 1
Combined, MOTNF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MOTNF + MRK for your $10,000?
Powertap Hydrogen Capital Corp. is a venture capital firm specializing in investments in early stage, buyouts. It prefers to invest in equity, bridge loans, secured loans, unsecured loans, convertible debentures, warrants and options, joint ventures, partnerships, royalties, streaming investments, net profit interests and other hybrid instruments. It focuses its investments in energy sector, oil and gas equipment and commercial aircraft sector. The firm prefers to invest in securities of private and publicly listed entities that are involved in a variety of industries including renewable energy includes hydrogen & fuel cell technologies, wind power, solar power and geothermal power. The firm invests bio-medical, pharmaceutical, and naturopathic sectors, which may include medical or recreational cannabis. The firm prefers to focus on investing in cannabis enterprises. The firm considers investments in North America. The firm does not invest in Canada and United States. The firm takes control position and majority stake in the companies. The company was formerly known as Clean Power Capital Corp. and changed its name to Powertap Hydrogen Capital Corp. in June 2021. Powertap Hydrogen Capital Corp. was founded in 1980 and is headquartered in Vancouver, Canada with additional offices in Hamilton, Bermuda and London, United Kingdom.
Full MOTNF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.